Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma.
Juliana Carvalho SantosNúria Profitós-PelejàMarcelo Lima RibeiroGael RouéPublished in: Cancers (2022)
Altogether, these data provide the first preclinical insight into the effect of simvastatin against MCL cells, suggesting that this agent might be considered for repurpose as a precise MCL therapy.